Skip to content

Medical emergency? What to do

Constipation drug effective, study suggests

3-RXPublished May 25, 20062 min read

Key points

  • Progenics Pharmaceuticals Inc. and Wyeth said on Tuesday that their experimental treatment for constipation caused by opioid painkillers proved effective in a late-stage clinical trial.
  • The study showed that 48 percent of severely constipated patients experienced a bowel movement within four hours of receiving their first dose of the drug, compared with 16 percent given a placebo.
  • Methylnaltrexone is designed to block the effect of the painkillers on opioid receptors outside the central nervous system.
  • The most common side effect was temporary abdominal cramping.

Progenics Pharmaceuticals Inc. and Wyeth said on Tuesday that their experimental treatment for constipation caused by opioid painkillers proved effective in a late-stage clinical trial.

The 133-patient study is the second pivotal-stage trial of the subcutaneous drug, called methylnaltrexone, in patients with painful, terminal illnesses, such as cancer and heart disease, who also suffer from constipation.

The study showed that 48 percent of severely constipated patients experienced a bowel movement within four hours of receiving their first dose of the drug, compared with 16 percent given a placebo. More than 70 percent of methylnaltrexone patients responded by the end of the first week of treatment.

Opioids such as morphine are widely used to lessen the suffering of the approximately 1.7 million Americans living with painful terminal illnesses. They block the perception of pain within the central nervous system, but also interact with receptors outside the brain and spinal cord, resulting in constipation and other side effects.

Methylnaltrexone is designed to block the effect of the painkillers on opioid receptors outside the central nervous system.

For those who responded in the trial, the median time to laxation was 30 minutes, and there were no reports of diminished pain relief.

The most common side effect was temporary abdominal cramping.

The data, presented here at the Digestive Disease Week annual meeting, confirm the results of the single-dose trial and show that the drug can work well over a two-week period, said Dr. Neil Slatkin, study investigator and director of the department of supportive care, pain and palliative medicine at City of Hope cancer center in Duarte, California.

"These patients are the sickest of the sick. Everything had been tried without success," he said.

Progenics and Wyeth plan to file for U.S. Food and Drug Administration approval of the drug early next year, by which time they expect to have an improved formulation that does not need to be refrigerated.

The companies will not need to conduct further human clinical trials of the more convenient, room-temperature formulation, said Dr. Robert Israel, senior vice president of medical affairs at Progenics.

Progenics in December reached a deal worth up to $416.5 million with Wyeth to develop and market the drug.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.